William Rees

Person

Seattle, WA, US

People

Patents Grantslast 30 patents

Information Patent Grant
CCL20 as a predictor of clinical response to IL23-antagonists
- Patent number 11,220,541
- Issue date Jan 11, 2022
- Amgen Inc.
- Robert W. Georgantas
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Prediction of clinical response to IL23-antagonists using IL23 path...
- Patent number 11,016,099
- Issue date May 25, 2021
- Amgen Inc.
- Robert W. Georgantas
- G01 - MEASURING TESTING
Information Patent Grant
Administration of alpha4beta7 hetero-dimer-specific antibody
- Patent number 9,914,779
- Issue date Mar 13, 2018
- Amgen Inc.
- Dominique Christian Borie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHODS OF TREATMENT OF AUTOIMMUNE DISORDERS USING ILT7 BINDING PRO...
- Publication number 20240287176
- Publication date Aug 29, 2024
- Viela Bio, Inc.
- Jorn DRAPPA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD40L ANTAGONIST AND USES THEREOF IN THE TREATMENT OF LUPUS NEPHRITIS
- Publication number 20240084024
- Publication date Mar 14, 2024
- Viela Bio, Inc.
- Gabor G. ILLEI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING NEUROMYELITIS OPTICA SPECTRUM DISORDER
- Publication number 20230406928
- Publication date Dec 21, 2023
- Viela Bio, Inc.
- William REES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF AN ANTI-CD19 ANTIBODY TO TREAT AUTOIMMUNE DISEASE
- Publication number 20230287114
- Publication date Sep 14, 2023
- Viela Bio, Inc.
- Dewei SHE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING IMMUNE MEDIATED PULMONARY INJURY
- Publication number 20230151093
- Publication date May 18, 2023
- Viela Bio, Inc.
- Gabor ILLEI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATMENT USING ILT7 BINDING PROTEINS
- Publication number 20220403020
- Publication date Dec 22, 2022
- Viela Bio, Inc.
- William REES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PREDICTION OF CLINICAL RESPONSE TO IL23-ANTAGONISTS USING IL23 PATH...
- Publication number 20220373539
- Publication date Nov 24, 2022
- Amgen Inc.
- Robert W. Georgantas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CCL20 AS A PREDICTOR OF CLINICAL RESPONSE TO IL23-ANTAGONISTS
- Publication number 20220144935
- Publication date May 12, 2022
- Amgen Inc.
- Robert W. Georgantas
- G01 - MEASURING TESTING
Information Patent Application
CD40L ANTAGONIST AND USES THEREOF
- Publication number 20210340200
- Publication date Nov 4, 2021
- Viela Bio, Inc.
- Jorn DRAPPA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CCL20 AS A PREDICTOR OF CLINICAL RESPONSE TO IL23-ANTAGONISTS
- Publication number 20200262907
- Publication date Aug 20, 2020
- Amgen Inc.
- Robert W. Georgantas
- G01 - MEASURING TESTING
Information Patent Application
PREDICTION OF CLINICAL RESPONSE TO IL23-ANTAGONISTS USING IL23 PATH...
- Publication number 20180252728
- Publication date Sep 6, 2018
- Amgen Inc.
- Robert W. Georgantas
- G01 - MEASURING TESTING

William Rees

Person

Patents Grantslast 30 patents

CCL20 as a predictor of clinical response to IL23-antagonists

Prediction of clinical response to IL23-antagonists using IL23 path...

Administration of alpha4beta7 hetero-dimer-specific antibody

Patents Applicationslast 30 patents

METHODS OF TREATMENT OF AUTOIMMUNE DISORDERS USING ILT7 BINDING PRO...

CD40L ANTAGONIST AND USES THEREOF IN THE TREATMENT OF LUPUS NEPHRITIS

METHODS OF TREATING NEUROMYELITIS OPTICA SPECTRUM DISORDER

USE OF AN ANTI-CD19 ANTIBODY TO TREAT AUTOIMMUNE DISEASE

METHODS OF TREATING IMMUNE MEDIATED PULMONARY INJURY

METHODS OF TREATMENT USING ILT7 BINDING PROTEINS

PREDICTION OF CLINICAL RESPONSE TO IL23-ANTAGONISTS USING IL23 PATH...

CCL20 AS A PREDICTOR OF CLINICAL RESPONSE TO IL23-ANTAGONISTS

CD40L ANTAGONIST AND USES THEREOF

CCL20 AS A PREDICTOR OF CLINICAL RESPONSE TO IL23-ANTAGONISTS

PREDICTION OF CLINICAL RESPONSE TO IL23-ANTAGONISTS USING IL23 PATH...